Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|August 15, 2022
Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic waveAlessandra Aiello, Adriano Grossi, Silvia Meschi, et al.
Vaccines|July 2, 2021
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 VaccinationVincenzo Puro, Concetta Castilletti, Chiara Agrati, et al.
Biomedicines|March 29, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid ArthritisAndrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Frontiers in Immunology|November 17, 2025
Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapiesAlessandra Aiello, Assunta Navarra, Shalom Haggiag, et al.
Journal of Translational Medicine|December 8, 2021
Multi-omics approach to COVID-19: a domain-based literature reviewChiara Montaldo, Francesco Messina, Isabella Abbate, et al.
International Journal of Molecular Sciences|May 27, 2023
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster DoseSerena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Microorganisms|July 2, 2021
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA VaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Frontiers in Immunology|March 21, 2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid ArthritisChiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology|October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis PatientsAndrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Pageof 6